| Gene symbol | TNFRSF17 | Synonyms | BCM, BCMA, CD269, TNFRSF13A | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p13.13 | dbXrefs | |
| Description | TNF receptor superfamily member 17 | ||||
| GTO ID | GTC3470 |
| Trial ID | NCT05893693 |
| Disease | Multiple Myeloma | Plasma Cell Leukemia |
| Altered gene | BCMA |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CT0594CP |
| Recruitment status | Recruiting |
| Title | Assess the Safety and Efficacy of CT0594CP Cells in Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia |
| Year | 2023 |
| Country | China |
| Company sponsor | Aibin Liang, MD, Ph.D. |
| Other ID(s) | CT0594CP-CG6020 |
| Cohort 1 | |||||||
|
|||||||